Table 1.
Sample Size and Details of Datasets Included in Study
| Dataset name | In PGC2 SZ study? | Country/countries of origin | Number of study participants | Gender (% female) | Median age | Age range |
|---|---|---|---|---|---|---|
| Bonn/Mannheim | Yes | Germany | 436 | 42 | 36 | 17–70 |
| PAGES | Yes | Germany | 148 | 37 | 39 | 19–70 |
| CATIE | Yes | United States | 350 | 23 | 43 | 18–65 |
| Hubin | Yes | Sweden | 77 | 30 | 45 | 25–70 |
| TOP | Yes | Norway | 286 | 43 | 29 | 17–62 |
| GROUP sample 1 | Yes | The Netherlands | 309 | 23 | 25 | 16–52 |
| GROUP sample 2 | Yes | The Netherlands | 119 | 24 | 25 | 15–45 |
| Ireland (PGC samples) | Yes | Ireland | 346 | 28 | 42 | 17–69 |
| Ireland (additional samples) | No | Ireland | 159 | 35 | 43 | 19–67 |
| EU-GEI Work Package 2 | No | France, Italy, Spain, the Netherlands, United Kingdom | 156 | 28 | 30 | 17–59 |
| Cardiff cognition | No | United Kingdom | 648 | 38 | 43 | 17–74 |
Note: PGC, psychiatric genomics consortium; PAGES, phenomics and genomics sample; CATIE, clinical antipsychotic trials for intervention effectiveness; TOP, Tematisk Omrade Psykoser, GROUP, genetic risk and outcome of psychosis; EU-GEI, European Union Gene-Environment Interaction. Number of study participants refers to those with genomic, phenotypic and covariate data.